Antigen-specific suppressor T lymphocytes in man.

Clin Immunol Immunopathol

CETUS Corporation, Emeryville, California 94608.

Published: November 1989

The cellular signals that lead to activation of suppressor T cells (Ts) as opposed to cytotoxic T cells (CTL) are unknown. This review describes an in vitro suppressor-induction system developed by us to characterize interactions among various T cells leading to the development of antigen-specific suppression. In this system, antigen-specific CD4+ inducer T cells are first activated with antigen-presenting cells (APC). Antigen-primed CD4+ inducer blasts are then cultured with fresh autologous CD8+ T cells in the absence of the priming antigen. CD8+ T cells isolated from this culture suppress the proliferative response of autologous CD4+ T cells to the priming antigen only. The activated CD8+ Ts lyse neither APC nor antigen-primed CD4+ inducer T cells and can be distinguished from their CD8+CD28+ CTL counterpart by their lack of expression of the CD28 molecule. Furthermore, the ability to induce CD8+ Ts is restricted to antigen-primed CD4+CD29+CD45R-p80+ (Leu8+) T cells. Antibody-mediated inhibition experiments suggest the involvement of CD3/TCR and class I MHC molecules on the surface of CD4+ inducer T cells and the CD2, CD3/TCR, CD8, and CD11a/CD18 molecules on the surface of CD8+ Ts during both the induction and the effector phase of Ts function. Furthermore, compatibility at the class I MHC genes between CD8+ Ts and CD4+ antigen-reactive T cells is required for effective suppression of CD4+ T cells. Together, these results suggest that human antigen-specific CD8+ Ts employ the TCR complex to recognize TCR and class I MHC molecules on the surface of autologous CD4+ inducer T cells during the induction and effector phases of Ts function, and the apparent antigen specificity of suppression reflects specificity for antigen receptors on CD4+ antigen-reactive T cells. This may be a common mechanism by which antigen-specific suppression is accomplished.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0090-1229(89)90066-4DOI Listing

Publication Analysis

Top Keywords

cd4+ inducer
20
inducer cells
16
cells
15
class mhc
12
molecules surface
12
cd4+
9
antigen-specific suppression
8
apc antigen-primed
8
antigen-primed cd4+
8
cd8+ cells
8

Similar Publications

Introduction: T helper 17 (Th17) cells have a significant effect in the pathogenesis of asthma, and signal transducer and activator of transcription 3 (STAT3) pathway activation is critical for Th17 cell differentiation. Timosaponin A-III (TA3) was reported to inhibit the STAT3 pathway. Here, we investigated whether TA3 improved asthma by inhibiting the STAT3 pathway.

View Article and Find Full Text PDF

Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity.

J Clin Invest

January 2025

State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

Stimulator of interferon genes (STING) agonists have been developed and tested in clinical trials for their antitumor activity. However, the specific cell population(s) responsible for such STING activation-induced antitumor immunity have not been completely understood. In this study, we demonstrated that endothelial STING expression was critical for STING agonist-induced antitumor activity.

View Article and Find Full Text PDF

How are autoreactive T cells induced and regulated in patients with autoimmune disease? This question lies at the core of understanding autoimmune disease pathologies, yet it has remained elusive due to host variability and the complexity of the immune system. In this issue of the JCI, Kramer and colleagues used autoimmune hepatitis (AIH) as a model to explore the maintenance of autoreactive CD4+ T cells specific to O-phosphoseryl-tRNA:selenocysteine tRNA synthase (SepSecS). The findings provide insight into the interaction between T cells and B cells in AIH pathogenesis that may reflect a shared mechanism among other autoimmune diseases.

View Article and Find Full Text PDF

A new twist on superantigen-activated autoimmune disease.

J Clin Invest

January 2025

Division of Rheumatology, Center of Excellence for Intestinal and Immunology Research, University of Alberta, Edmonton, Alberta, Canada.

Superantigen-induced (Sag-induced) autoimmunity has been proposed as a mechanism for many human disorders, without a clear understanding of the potential triggers. In this issue of the JCI, McCarthy and colleagues used the SKG mouse model of rheumatoid arthritis to characterize the role of Sag activity in inflammatory arthritis by profiling arthritogenic naive CD4+ T cells. Within the diseased joints, they found a marked enrichment of T cell receptor-variable β (TCR-Vβ) subsets that were reactive to the endogenously encoded mouse mammary tumor virus (MMTV) Sag.

View Article and Find Full Text PDF

Background: Mycobacterium bovis BCG is the human tuberculosis vaccine and is the oldest vaccine still in use today with over 4 billion people vaccinated since 1921. The BCG vaccine has also been investigated experimentally in cattle and wildlife by various routes including oral and parenteral. Thus far, oral vaccination studies of cattle have involved liquid BCG or liquid BCG incorporated into a lipid matrix.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!